| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/15/2009 | WO2009007112A2 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 01/15/2009 | WO2009006732A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008135661A3 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
| 01/15/2009 | WO2008110699A3 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | WO2008076247A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 01/15/2009 | WO2008076246A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | US20090018331 Condensed imidazole derivatives |
| 01/15/2009 | US20090018206 Prevention of hypotension and stabilization of blood pressure in hemodialysis patients |
| 01/15/2009 | US20090018193 Essential fatty acids in the prevention of cardiovascular events |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018181 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/15/2009 | US20090018170 5-lipoxygenase-activating protein (flap) inhibitors |
| 01/15/2009 | US20090018137 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018131 Quinazoline derivatives as p13 kinase inhibitors |
| 01/15/2009 | US20090018120 Amidine derivatives and their applications as a medicament |
| 01/15/2009 | US20090018114 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | US20090018110 Haptoglobin genotyping for prognosis and treatment of chronic vasospasm following subarachnoid hemorrhage (SAH) |
| 01/15/2009 | US20090018103 Diaminoalkane Aspartic Protease Inhibitors |
| 01/15/2009 | US20090018092 Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids |
| 01/15/2009 | US20090018078 Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018061 Compositions and Methods for Treating Cardiac Conditions |
| 01/15/2009 | US20090018054 Cholesteryl Ester Transfer Protein Inhibitors |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017465 Compound Screening Using Cardiomyocytes |
| 01/15/2009 | US20090017145 Tri ascorbate formulation |
| 01/15/2009 | US20090017043 Connective tissues growth factor antibodies |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017028 Antigen binding fragments (fab fragments) binds to a plurality of beta-chemokines; glomerulonephritis, scleroderrna, cirrhosis, multiple sclerosis, lupus nephritis, atherosclerosis, inflammatory bowel disease or rheumatoid arthritis; antiinflammatory agents |
| 01/15/2009 | US20090017019 Methods and compositions for modulating bmp-10 activity |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | US20090016965 Internal image antibodies for optical imaging and therapy |
| 01/15/2009 | CA2693400A1 Methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| 01/15/2009 | CA2692805A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |
| 01/15/2009 | CA2692801A1 Methods of inhibiting the formation of amyloid-.beta. diffusable ligands using acylhydrazide compounds |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2692485A1 Compounds and methods for modulating rho gtpases |
| 01/15/2009 | CA2691898A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | CA2682096A1 Klotho beta |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014652A1 Activating agent for peroxisome proliferator activated receptor |
| 01/14/2009 | EP2014651A1 Compounds and methods for modulating Rho GTPases |
| 01/14/2009 | EP2014296A1 Novel strategies for increasing the reperfusion in obstructed blood vessel |
| 01/14/2009 | EP2014291A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment |
| 01/14/2009 | EP2014284A1 Pharmaceutical compositions and uses |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP2013205A1 Heterocyclic substituted, anellated pyrazole derivative and its uses |
| 01/14/2009 | EP2013184A1 Sulfonamide compounds useful as edg receptor modulators |
| 01/14/2009 | EP2013165A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit. |
| 01/14/2009 | EP2012828A2 Compositions and methods for the treatment of cardiovascular disease |
| 01/14/2009 | EP2012788A2 Pre-mixed, ready-to-use iv bolus compositions and methods of use |
| 01/14/2009 | EP2012775A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators |
| 01/14/2009 | EP2012760A2 Purine derivatives for use as adenosin a2a receptor agonists |
| 01/14/2009 | EP2012759A1 Purine derivatives as a2a receptor agonists |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1516620B1 Rifampicin for treating angiogenesis |
| 01/14/2009 | EP1515732B1 Cerebral protection with a gas comprising xenon |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1451151B1 Hydroperylene derivatives |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1183025B1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | CN101346471A Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer |
| 01/14/2009 | CN101346386A Process for the preparation of S-(+)-clopidogrel by optical resolution |
| 01/14/2009 | CN101346365A Agent for treatment of circulatory failure |
| 01/14/2009 | CN101346339A Cyclopropylacetic acid derivatives and use thereof |
| 01/14/2009 | CN101346338A Dicarboxylic acid derivatives and their use |
| 01/14/2009 | CN101346140A Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 01/14/2009 | CN101346138A Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343299A Lxeris sonchifolia(bunge)hance flavone extract, preparation method and application thereof |
| 01/14/2009 | CN101343249A Preparation of 3-(3-chlorine propyl)-7, 8-di methoxy-1, 3-dihydrogen-2H-3-benzo aza -ketone |
| 01/14/2009 | CN101343224A Dandelion native ¿CB, extraction separation method and used thereof |
| 01/14/2009 | CN101342356A Traditional Chinese medicine preparation for congestion retardarce, haemal tube obstruction and preparation method thereof |
| 01/14/2009 | CN101342349A Traditional Chinese medicine for treating hyperpiesis and myocardium disease |
| 01/14/2009 | CN101342346A Drop pill for treating stenocardia caused by coronary disease |
| 01/14/2009 | CN101342344A Chinese medicine for treating piles |
| 01/14/2009 | CN101342326A Preparation method for traditional Chinese medicine for treating fire excess from Yin deficiency type nodal tachyeardia |
| 01/14/2009 | CN101342322A Oral traditional Chinese medicine for treating hemorrhoids |
| 01/14/2009 | CN101342314A Traditional Chinese medicine for treating cardiovascular disease, preparation method and uses thereof |